Literature DB >> 2960948

Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home.

G Lockitch1, V K Singh, M L Puterman, W J Godolphin, S Sheps, A J Tingle, F Wong, G Quigley.   

Abstract

Abnormalities of humoral and cell-mediated immunity have been described in Down syndrome but reported findings have been inconsistent. Confounding factors have included age, institutional versus home life, hepatitis B antigenemia, and zinc deficiency. To clarify this problem, we studied 64 children with Down syndrome (DS) compared with an age-matched control group. All children had always lived at home. All the DS children were negative for hepatitis B surface antigen. Serum zinc concentration in the DS group was on average 12 micrograms/dl lower than age-matched control children. They also had significantly lower levels of immunoglobulin M, total lymphocyte count, T and B lymphocytes, and T helper and suppressor cells. In vitro lymphocyte response to phytohemagglutinin and concanavalin A was significantly reduced at all ages in the DS group. Lymphocyte response to pokeweed mitogen increased with age in control children but decreased in the DS children. By 18 yr, the mean response for DS was 60000 cpm lower than controls. The DS group had significantly higher concentrations of immunoglobulins A and G than controls and the difference increased with age. Complement fractions C3 and C4 were also higher in the DS group at all ages. The number of HNK-1 positive cells was higher in the DS group than controls at all ages. When hepatitis and institutionalization are excluded as confounding factors, DS children still differ in both humoral and cell-mediated immunity from an age-matched control group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960948     DOI: 10.1203/00006450-198711000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Prognosis of Down's syndrome with acute leukaemia.

Authors:  G A Levitt; C A Stiller; J M Chessells
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

Review 2.  Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia.

Authors:  Soma Jyonouchi; Artemio M Jongco; Jennifer Puck; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

3.  Lack of age-associated LFA-1 up-regulation and impaired ICAM-1 binding in lymphocytes from patients with Down syndrome.

Authors:  S J Lin; J Y Wang; L B Klickstein; K P Chuang; J Y Chen; J F Lee; C C Shieh
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

4.  Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: A Children's Oncology Group study.

Authors:  Simona Ognjanovic; Susan Puumala; Logan G Spector; Franklin O Smith; Leslie L Robison; Andrew F Olshan; Julie A Ross
Journal:  Pediatr Blood Cancer       Date:  2009-05       Impact factor: 3.167

Review 5.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

Review 6.  Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: Lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium.

Authors:  Amene Saghazadeh; Maryam Mahmoudi; Atefeh Dehghani Ashkezari; Nooshin Oliaie Rezaie; Nima Rezaei
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

7.  Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.

Authors:  Larissa Haertle; Tobias Müller; Roy Lardenoije; Anna Maierhofer; Marcus Dittrich; Renzo J M Riemens; Samantha Stora; Mathilde Roche; Markus Leber; Steffi Riedel-Heller; Michael Wagner; Martin Scherer; Aimé Ravel; Clotilde Mircher; Cecile Cieuta-Walti; Sophie Durand; Daniel L A van de Hove; Per Hoffmann; Alfredo Ramirez; Thomas Haaf; Nady El Hajj; André Mégarbané
Journal:  Clin Epigenetics       Date:  2019-12-16       Impact factor: 6.551

Review 8.  Down syndrome, accelerated aging and immunosenescence.

Authors:  Noémie Gensous; Maria Giulia Bacalini; Claudio Franceschi; Paolo Garagnani
Journal:  Semin Immunopathol       Date:  2020-07-23       Impact factor: 9.623

9.  Phenotype of apoptotic lymphocytes in children with Down syndrome.

Authors:  Solaf M Elsayed; Ghada M Elsayed
Journal:  Immun Ageing       Date:  2009-03-06       Impact factor: 6.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.